Singapore markets closed
Straits Times Index
3,144.76 -38.85 (-1.22%) S&P 500
5,061.82 -61.59 (-1.20%) Dow
37,735.11 -248.13 (-0.65%) Nasdaq
15,885.02 -290.08 (-1.79%) Bitcoin USD
62,764.03 -3,510.85 (-5.30%) CMC Crypto 200
885.54 0.00 (0.00%)
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.52 |
| Open | 5.50 |
| Bid | 5.53 x 400 |
| Ask | 5.56 x 400 |
| Day's range | 5.47 - 5.67 |
| 52-week range | 1.58 - 6.46 |
| Volume | |
| Avg. volume | 1,508,801 |
| Market cap | 1.709B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amneal to Report First Quarter 2024 Results on May 3, 2024
BRIDGEWATER, N.J., April 10, 2024--Amneal to Report First Quarter 2024 Results on May 3, 2024
- Business Wire
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
BRIDGEWATER, N.J., March 28, 2024--Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
- Business Wire
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
BRIDGEWATER, N.J., March 25, 2024--Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
© 2024 Yahoo. All rights reserved.